PRADAXA is the trademarked name for a blood thinner manufactured by BOEHRINGER INGELHEIM. PRADAXA (DABIGARAN EXTILATE) was approved by the U.S. Food & Drug Administration in October 2010. It is intended for use in patients with non-valvular atrial fibrillation, a heart condition where blood may pool in the heart placing the patient at risk of a blood clot. Blood clots can travel and contribute to, or create potentially fatal health conditions. By their very nature, all blood thinners, or anticoagulants, carry the increased risk of bleeding. However, PRADAXA (DABIGATRAN EXTILATE) is unique because it has no known “antidote” or quick reversal agent. As a result, a minor event, fall, or cut can present create an emergency. Because PRADAXA (DABIGATRAN EXTILATE) has only been available since October 2010, there is limited information, or established guidelines to provide a roadmap for dealing with PRADAXA CASES and emergencies.
PRADAXA CASES & BLEEDING SYMPTOMS/SIDE EFFECTS.
Serious side effects from PRADAXA (DABIGATRAN EXTILATE) may require immediate medical attention. Such side effects include the following:
- Bleeding from a cut that lasts longer than usual.
- Vomitting material that is blood or looks like coffee grounds.
- Coughing up blood.
- Red or Black, tarry stools.
- Pink or Brown Urine.
- Unusual Bruising or Bleeding.
- Bleeding from the Gums.
- Frequent Nosebleeds.
- Heavy Menstrual Bleeding.
- Swelling of the Arms, Hands, Feet, Ankles or Lower legs.
- Headache.
- Dizziness.
- Weakness.
The symptoms above are considered serious and require medical attention or intervention. Additional information regarding “What is PRADAXA (DABIGATRAN EXTILATE)” is available from Medline Plus On-Line.
PRADAXA CASES involve serious side effects from PRADAXA (DABIGATRAN EXTILATE) resulting in death, disability or complications that involve prolonged medical care or treatment. The sponsor of this site, Gabriel F. Zambrano, P.A., is investigating PRADAXA CASES. FREE CASE EVALUATION are available upon request through the use of the contact form below.
Pradaxa® Cases Involve PRADAXA BLEEDING, BLEEDS or BLOOD.
#PRADAXA #DABIGATRAN #BI #BOEHRINGERINGELHEIM #FDA #RECALLS
#PRADAXARECALL #BLEEDING #BLEEDS #PRADAXALAWSUITS #PRADAXACASES
#PRADAXALAWYERS #PRADAXAATTORNEYS #PRADAXABLEEDING